Market Overview

Current Estimates On TreeHouse Foods Could Indicate Significant Earnings Miss For The Year


In a report published Friday, Stifel analyst Christopher Growe reiterated a Buy rating on TreeHouse Foods (NYSE: THS), but lowered the price target from $95.00 to $90.00.

In the report, Stifel noted, "TreeHouse reported its 4Q14 EPS of $0.99, up 1%, and $0.18 below our estimate. This quarter came in below expectations due to a significant inventory reduction late in 4Q14 from a large customer, slower consumption at Flagstone (nuts, trail mixes, etc.), and currency headwinds (Canadian dollar)."

The report continued, "The company provided EPS guidance of $3.80 to $3.95 which was well below our consensus matching $4.15 EPS estimate for 2015 and if left there would indicate a significant earnings miss for the year; however, this earnings guidance includes an unprecedented $0.30 drag on EPS from FX."

TreeHouse Foods closed on Thursday at $81.57.

Latest Ratings for THS

Aug 2019UpgradesHoldBuy
Jul 2019UpgradesMarket PerformOutperform
Apr 2019UpgradesMarket PerformOutperform

View More Analyst Ratings for THS
View the Latest Analyst Ratings

Posted-In: Christopher Growe StifelAnalyst Color Price Target Analyst Ratings


Related Articles (THS)

View Comments and Join the Discussion!

Latest Ratings

CDMOStephens & Co.Initiates Coverage On8.0
XHRBMO CapitalInitiates Coverage On21.0
AMGNBank of AmericaReinstates215.0
BIIBBank of AmericaReinstates200.0
BMRNBank of AmericaReinstates90.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Reputation Rebuilding At Rayonier Still In Early Phases, Positive Results Expected

Martin Marietta Refrained From Specifics At Analyst Day, Cash Flow Strength Expected To Continue